Abstract
During the 1960s at Rotta Research Laboratorium, Rovati [1] developed a gastrin receptor antagonist named proglumide, i.e., DL-4-benzamido-N, N-dipropyl-glutaramic acid. Proglumide has been used for several years for the treatment of peptic ulcer.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Rovati AL (1968) The relationship between chemical structure of a new dicarboxylic amino-acid derivative and antigastrin activity in the rat. Br J Pharmacol 34:677–682
Hahne WF, Jensen RT, Lemp GF, Gardner JD (1981) Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists. Proc Natl Acad Sci USA 78:6304–6308
Makovec F, Chistè R, Bani M, Revel L, Setnikar I, Rovati AL (1986) New glutamic and aspartic derivatives with potent CCK-antagonistic activity. Eur J Med Chem 21:9–20
Makovec F, Chistè R, Bani M, Pacini MA, Setnikar I, Rovati LA (1985) New glutaramic acid derivatives with potent, competitive and specific, cholecystokinin-antagonistic activity. Arzneimittelforschung 35:1048–1051
Setnikar I, Bani M, Cereda R, Chistè R, Makovec F, Pacini MA, Revel L, Rovati LC, Rovati LA (1987) Pharmacological characterization of a new potent and specific nonpolypeptidic cholecystokinin antagonist. Arzneimittelforschung 37:703–707
Makovec F, Bani M, Chistè R, Revel L, Rovati LC, Rovati LA (1986) Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity. Arzneimittelforschung 36:98–102
Jensen RT, Zhon ZC, Murphy RB, Jones SW, Setnikar I, Rovati LA, Gardner JD (1986) Structural features of various proglumide-related cholecystokinin receptor antagonists. Am J Physiol 251:G839–G846
Makovec F, Bani M, Cereda R, Chisté R, Pacini MA, Revel L, Rovati LC (1987) Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK. Pharmacol Res Commun 19:41–51
Makovec F, Bani M, Cereda R, Chisté R, Pacini MA, Revel L, Rovati LA, Rovati LC, Setnikar I (1987) Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonists. Arzneimittelforschung 37:1265–1268
Setnikar I, Bani M, Cereda R, Chisté R, Makovec F, Pacini MA, Revel L (1987) Anticholecystokinin activities of loxiglumide. Arzneimittelforschung 37: 1168–1171
Rovati LC, Bani M, Makovec F, Revel L, Setnikar I (1987) Lorglumide and loxiglumide: two potent and specific antagonists of peripheral CCK. Excerpta Med Int Congr Ser 766:45–48
Makovec F, Bani M, Chisté R, Revel L, Rovati LC, Setnikar I (1986) Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats. Regul Pept 16:281–290
Makovec F, Bani M, Cereda R, Chisté R, Revel L, Rovati LC, Setnikar I, Rovati LA (1986) Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and mice. Peptides 7:1159–1164
Setnikar I, Bani M, Cereda R, Chisté R, Pacini MA, Revel L (1987) Loxiglumide protects against experimental pancreatitis. Arzneimittelforschung 37:1172–1174
Setnikar I, Chisté R, Makovec F, Rovati LC, Warrington SJ (1988) Pharmacokinetics of loxiglumide after single intravenous or oral doses in man. Arzneimittelforschung 38:716–720
Setnikar I, Chisté R, Giacovelli G, Rovati LC (1989) Pharmacokinetics and tolerance of repeated oral doses of loxiglumide. Arzneimittelforschung 39: 1454–1459
Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JBMJ, Zach D, Rovati LC, Stalder GA (1989) Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2:12–15
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rovati, L.C. (1991). Pentanoic Acid Derivatives. In: Adler, G., Beglinger, C. (eds) Cholecystokinin Antagonists in Gastroenterology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76362-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-76362-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76364-9
Online ISBN: 978-3-642-76362-5
eBook Packages: Springer Book Archive